The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Houten, N.
Right arrow Articles by Budd, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Houten, N.
Right arrow Articles by Budd, R. C.

The Journal of Immunology, Vol 149, Issue 7 2513-2517, Copyright © 1992 by American Association of Immunologists


ARTICLES

Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes

N Van Houten and RC Budd
Department of Medicine, University of Vermont, Burlington 05405.

MRL-lpr/lpr (lpr) mice develop a polyclonal accumulation of abnormal peripheral T lymphocytes, which bear surface alpha beta TCR, CD3, and the B220 isoform of CD45, but lack CD4, CD8, and CD2. These T cells have a constitutively phosphorylated CD3 zeta chain and manifest a defect in signal transduction that results in a lack of IL-2 production and proliferation. We investigated whether this signaling abnormality might contribute to their accumulation via a defect in T cell elimination in the periphery. T cell deletion occurs through a process of programmed cell death with DNA degradation, or apoptosis. Viable lymphocytes from lpr mice were found to undergo rapid programmed cell death in culture within 4 h without additional activation, which was not observed in lymphocytes from normal MRL-+/+ or C57BL/6-+/+ mice. Both nonmature B220+ and mature B220- T lymphocytes from lpr mice display this accelerated programmed cell death, indicating that this is a defect affecting all peripheral T lymphocytes in lpr mice. In vitro apoptosis of lpr T cells could be inhibited with PMA, a stimulator of protein kinase C. Thus, the massive accumulation of T lymphocytes in the lymphoid tissue of lpr mice is not due to a defect in their ability to undergo programmed cell death in vitro. The activation state of lpr T cells may contribute to their rapid degradation of DNA in vitro.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Sengupta, P. Jayaraman, P. M. Chilton, C. R. Casella, and T. C. Mitchell
Unrestrained Glycogen Synthase Kinase-3beta Activity Leads to Activated T Cell Death and Can Be Inhibited by Natural Adjuvant
J. Immunol., May 15, 2007; 178(10): 6083 - 6091.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Do, A. Q. Rafi-Janajreh, R. J. Mckallip, P. S. Nagarkatti, and M. Nagarkatti
Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease
Int. Immunol., November 1, 2003; 15(11): 1327 - 1340.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. Potter, J. Cortes-Hernandez, P. Quartier, M. Botto, and M. J. Walport
Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells
J. Immunol., March 15, 2003; 170(6): 3223 - 3232.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Wang, X. Fan, C. Lindholm, M. Bennett, J. O'Connoll, F. Shanahan, E. G. Brooks, V. E. Reyes, and P. B. Ernst
Helicobacter pylori Modulates Lymphoepithelial Cell Interactions Leading to Epithelial Cell Damage through Fas/Fas Ligand Interactions
Infect. Immun., July 1, 2000; 68(7): 4303 - 4311.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. L. Stoll and J. Gavalchin
Systemic lupus erythematosus--messages from experimental models
Rheumatology, January 1, 2000; 39(1): 18 - 27.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. Odaka and T. Mizuochi
Role of Macrophage Lysosomal Enzymes in the Degradation of Nucleosomes of Apoptotic Cells
J. Immunol., November 15, 1999; 163(10): 5346 - 5352.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. F. Mixter, J. Q. Russell, G. J. Morrissette, C. Charland, D. Aleman-Hoey, and R. C. Budd
A Model for the Origin of TCR-{alpha}{beta}+ CD4-CD8- B220+ Cells Based on High Affinity TCR Signals
J. Immunol., May 15, 1999; 162(10): 5747 - 5756.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
T Papo, C Parizot, M Ortova, J-C Piette, C Frances, P Debre, P Godeau, and G Gorochov
Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus
Lupus, September 1, 1998; 7(7): 455 - 461.
[Abstract] [PDF]


Home page
JEMHome page
X. Fan, S. E. Crowe, S. Behar, H. Gunasena, G. Ye, H. Haeberle, N. Van Houten, W. K. Gourley, P. B. Ernst, and V. E. Reyes
The Effect of Class II Major Histocompatibility Complex Expression on Adherence of Helicobacter pylori and Induction of Apoptosis in Gastric Epithelial Cells: A Mechanism for T Helper Cell Type 1-mediated Damage
J. Exp. Med., May 18, 1998; 187(10): 1659 - 1669.
[Abstract] [Full Text] [PDF]


Home page
ADRHome page
E.S. Sobel
Cellular Interactions in the LPR and GLD Models of Systemic Autoimmunity
Advances in Dental Research, April 1, 1996; 10(1): 76 - 80.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.